Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma
Hong Wu, Xuefeng Leng, Qianshi Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3131-3144
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer
Xue‐Yuan Bi, Jihan Wang, Cuicui Liu
Biomolecules (2024) Vol. 14, Iss. 8, pp. 917-917
Open Access | Times Cited: 3
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy
Yao Jiang, Dingjiacheng Jia, Yong Sun, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 7
Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test
Qi Huang, Zheng Liu, Yipei Yu, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 4, pp. 694-700
Closed Access | Times Cited: 2
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
Athina A. Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1279-1279
Open Access | Times Cited: 2
Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1+ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
Zhen-Yang Geng, Feng Li, Zhichang Yang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access | Times Cited: 2
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
Claudia Lombardo, Rosario Fazio, Marta Sinagra, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1083-1083
Open Access | Times Cited: 2
A cross-cohort study identifies potential oral microbial markers for esophageal squamous cell cancer
Yan-Xiang Yu, Lei Xia, Z. Wang, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111453-111453
Open Access | Times Cited: 2
Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression
Li Yuan, Li-Bin Pan, Yunzhe Wang, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Relevance of harmful intratumoral microbiota in cancer progression and its clinical application
Runze Yu, Sheng Wang, Lei Han
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117238-117238
Open Access | Times Cited: 1
The gut microbiome modulate response to immunotherapy in cancer
Shanshan Jiang, Zi‐Ran Kang, Yingxuan Chen, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 1
Streptococcus anginosus in the development and treatment of precancerous lesions of gastric cancer
Su-Ting Qian, Hao-Yu Zhao, Feifei Xie, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 9, pp. 3771-3780
Open Access | Times Cited: 1
Tumor‐Resident Microbiota‐Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients
Hong Wu, Qianshi Liu, Jingpei Li, et al.
Advanced Science (2024) Vol. 11, Iss. 41
Open Access | Times Cited: 1
Microbiome, metabolome and transcriptome analyses in esophageal squamous cell carcinoma: Insights into immune modulation by F. nucleatum
Xue Zhang, Jing Han, Yudong Wang, et al.
Protein & Cell (2024)
Open Access | Times Cited: 1
The emerging role of intra-tumoral bacteria
Giovanni Brandi, Giorgio Frega
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 2, pp. 800-802
Open Access
Mechanisms by Which the Intratumoral Microbiome May Potentiate Immunotherapy Response
Dalissa Negrón‐Figueroa, Lauren E. Colbert
Journal of Clinical Oncology (2024) Vol. 42, Iss. 28, pp. 3350-3352
Closed Access
PRAD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3
Lanlin Hu, Mingxin Liu, Bo Tang, et al.
Cancer Gene Therapy (2024)
Closed Access
Intratumoral microbiota: a new force in the development and treatment of esophageal cancer
Taile Jing, Dong Tang
Clinical & Translational Oncology (2024)
Closed Access
Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Kin Lam Yu, Sj Shen
European Journal of Cancer (2024) Vol. 216, pp. 115195-115195
Open Access
Does microbiota composition act as predictive signature for the evaluation of chemoimmunotherapy response efficacy?
Serena Martinelli, Ingrid Lamminpää, Amedeo Amedei
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 529-532
Open Access
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy
Fyza Y. Shaikh, Seoho Lee, James R. White, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3644-3644
Open Access
Distribution and Antimicrobial Susceptibility Profiles of Pathogens in Patients With Esophageal Cancer From 2013 to 2022: A Retrospective Study
Hongwei Meng, Yulan Wang, Zhifu Li, et al.
Health Science Reports (2024) Vol. 7, Iss. 12
Closed Access
Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses
Zakia Harmak, Abdou-samad Kone, Amina Ghouzlani, et al.
Immune Network (2024) Vol. 24, Iss. 6
Open Access
Previous Page - Page 2

Scroll to top